1. This figure illustrates the importance of heart failure consideration in primary endpoint trials with hypoglycemic agents.
This figure illustrates the importance of heart failure consideration in primary endpoint trials with hypoglycemic agents. A retrospective cohort study6 with nearly 50 million lives found a high incidence of heart failure compared to the classic primary endpoints in most diabetes trials. Adapted from Ref. 6.
Vani P. Sanon et al. Clin Diabetes 2014;32:
©2014 by American Diabetes Association